K
Kojin Therapeutics
1 follower
Kojin is pioneering cell-state and ferroptosis biology and cutting-edge drug discovery to develop first-in-class small-molecule treatments that modulate ferroptosis.
Org chart
Harvey J. Berger
Chairman, Chief Executive Officer & President
Harvey J. Berger
Collapse
Upgrade to view 3 reports
Board & advisors
Stuart Schreiber
Co-Founder, Director & Chair, Scientific Advisory Board
Benjamin Cravatt
Co-Founder & Scientific Advisory Board Member
Stephanie Dougan
Co-Founder & Scientific Advisory Board Member
Sean Morrison
Scientific Advisory Board Member
Joel Barrish
Scientific Advisory Board Member
George Demetri
Scientific Advisory Board Member
Steven Davidsen
Scientific Advisory Board Member
Morris J. Birnbaum
Scientific Advisory Board Member
Amir Nashat
Director
Nagesh Mahanthappa
Director
AJ Ferraro
Director
Eric de La Fortelle
Director
Christina Vorvis
Board Observer
Steven Neier
Board Observer
Fabio Pucci
Board Observer
Benjamin Neel
Scientific Advisory Board Member
Eric Winer
Scientific Advisory Board Member